AZLatina
banner
endrarediseases.bsky.social
AZLatina
@endrarediseases.bsky.social
Blue Dog Dem. Rare Disease Patient Advocate for Amyloidosis that killed my Mom & ALS that is killing my friends. Passionate about Enviro Justice, Foster Care & Gun Safety. Proud GGD of a Righteous Gentile murdered by Nazis. 💙LA sports.
Pinned
People with terminal #RareDiseases urgently need DISRUPTIVE policy change & a conditional approval pathway at FDA.

32k people with 100% fatal #ALS like Brian Wallach are #DyingWaiting when drugs could help them live.

Humanity & science can co-exist.

#EndALS
@bsw5020.bsky.social
Reposted by AZLatina
Regenxbio says gene therapy strengthened boys with Duchenne muscular dystrophy; muscle performance tests in small trial seen as step to accelerated approval

www.statnews.com/2024/11/18/d...
Regenxbio says gene therapy strengthened boys with Duchenne muscular dystrophy
Based on a small trial with positive muscle performance data, Regenxbio is expected to pursue approval of its gene therapy for Duchenne muscular dystrophy.
www.statnews.com
November 18, 2024 at 12:42 PM
Reposted by AZLatina
Encouraging sign as Capricor seeks FDA approval of deramiocel for Duchenne Muscular Dystrophy based on encouraging data ipscell.com/2024/11/capr... #stemcells
Capricor seeks FDA approval of deramiocel for Duchenne based on encouraging data - The Niche
Stem cell biologist discusses very encouraging data from Capricor on Duchenne Muscular Dystrophy and future prospects.
ipscell.com
November 8, 2024 at 4:21 PM
Reposted by AZLatina
New #BrainDev journal paper: Safety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up. #DMD. tinyurl.com/3eurb55v
Safety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up
Duchenne muscular dystrophy (DMD) is a hereditary neuromuscular disorder characterized by severe, progressive muscle wasting. Viltolarsen, a formulati…
tinyurl.com
November 17, 2024 at 4:58 PM
Reposted by AZLatina
Mayo clinic liver Amyloid series

62% AL
25% ALECT2
7% AApo AI
4% AA
2% ATTR
1% lysozyme
November 16, 2024 at 10:59 PM
Reposted by AZLatina
Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients https://www.biorxiv.org/content/10.1101/2024.03.09.584228v1
Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients https://www.biorxiv.org/content/10.1101/2024.03.09.584228v1
ATTR amyloidosis is a relentlessly progressive disease caused by the misfolding and systemic accumul
www.biorxiv.org
March 11, 2024 at 7:20 AM
Reposted by AZLatina
The MND Association, My Name'5 Doddie Foundation and Darby Rimmer Foundation have funded our project with the Mario Negri Institute in Italy to study whether there is a link between #ALS #MND and professional football. Read about it here:
www.mndassociation.org/media/latest...

@ukmndri.bsky.social
New research project investigates potential link between professional football and MND
New research project investigates potential link between professional football and MND
www.mndassociation.org
November 16, 2024 at 11:40 AM
People with terminal #RareDiseases urgently need DISRUPTIVE policy change & a conditional approval pathway at FDA.

32k people with 100% fatal #ALS like Brian Wallach are #DyingWaiting when drugs could help them live.

Humanity & science can co-exist.

#EndALS
@bsw5020.bsky.social
November 17, 2024 at 9:55 PM